Evidence map›Paper›PMID 29392884›Full record

ReviewJournal of cellular and molecular medicine2018

Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer.

Gang Yang, Tianyi Shen, Xiaoming Yi, Zhengyu Zhang, Chaopeng Tang, Longxin Wang, Yulin Zhou, Wenquan Zhou

Open access · goldAbstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Long Non-coding RNAs, LncSub-cellular biochemistry · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Macleayins A FromFrontiers in pharmacology · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Gang YangDepartment of Urology, Jinling Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.ORCID 0000-0001-9708-6952
Tianyi ShenDepartment of Urology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, China.
Xiaoming YiDepartment of Urology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, China.
Zhengyu ZhangDepartment of Urology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, China.
Chaopeng TangDepartment of Urology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, China.
Longxin WangDepartment of Urology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, China.
Yulin ZhouDepartment of Urology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, China.
Wenquan ZhouDepartment of Urology, Jinling Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Nanjing General Hospital of Nanjing Military Command · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long non-coding RNAs (lncRNAs) are non-protein-coding transcripts in the human genome which perform crucial functions in diverse biological processes. The abnormal expression of some lncRNAs has been found in tumorigenesis, development and therapy resistance of cancers. They may act as oncogenes or tumour suppressors and can be used as diagnostic or prognostic markers, prompting their therapeutic potentials in cancer treatments. Studies have indicated that many lncRNAs are involved in the regulation of several signal pathways, including Wnt/β-catenin signalling pathway, which has been reported to play a significant role in regulating embryogenesis, cell proliferation and controlling tumour biology. Emerging evidences have suggested that lncRNAs can interact with several components of the Wnt/β-catenin signalling pathway to regulate the expression of Wnt target genes in cancer. Moreover, the expression of lncRNAs can also be influenced by the pathway. Nevertheless, Wnt/β-catenin signalling pathway-related lncRNAs and their interactions in cancer are not systematically analysed before. Considering these, this review emphasized the associations between lncRNAs and Wnt/β-catenin signalling pathway in cancer initiation, progression and their therapeutic influence. We also provided an overview on characteristics of lncRNAs and Wnt/β-catenin signalling pathway and discussed their functions in tumour biology. Finally, targeting lncRNAs or/and molecules associated with the Wnt/β-catenin signalling pathway may be a feasible therapeutic method in the future.

Indexed as

AnimalsCarcinogenesisDisease ProgressionDrug Resistance, NeoplasmHumansNeoplasmsRNA, Long NoncodingWnt Signaling PathwayRNA, Long Noncodingcancerlong non-coding RNAWnt/β-catenin signalling pathway

Identifiers

PMID29392884
PMCPMC5867104
OpenAlexW2792502960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.